Previous works have demonstrated the beneficial effects of Myr against different types of cancer, through the inhibition of protein kinases in distinct intracellular signaling pathways such as PI3K-PKB/Akt/mTOR, MEK1, Fyn and JAK1-STAT3, among others [22–24]. This evidence concerns the gene AKT1 and cancer.